Jim Simons acquired 4.94M Novo Nordisk shares worth $277M. That's 0.35% of their equity portfolio (42nd largest holding). The first Novo Nordisk trade was made in Q2 2013. Since then Jim Simons bought shares twenty more times and sold shares on 28 occasions. The stake costed the investor $225M, netting the investor a gain of 23% so far.